Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · IEX Real-Time Price · USD
2.390
-0.060 (-2.45%)
At close: Jul 19, 2024, 4:00 PM
2.400
+0.010 (0.42%)
Pre-market: Jul 22, 2024, 7:22 AM EDT
Esperion Therapeutics Market Cap
Esperion Therapeutics has a market cap or net worth of $407.30 million as of July 22, 2024. Its market cap has increased by 194.50% in one year.
Market Cap
407.30M
Enterprise Value
729.56M
1-Year Change
194.50%
Ranking
Category
Stock Price
$2.39
Market Cap Chart
Since June 26, 2013, Esperion Therapeutics's market cap has increased from $204.10M to $407.30M, an increase of 99.56%. That is a compound annual growth rate of 6.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 452.80M | 33.18% |
| Dec 29, 2023 | 340.00M | -25.93% |
| Dec 30, 2022 | 459.00M | 215.68% |
| Dec 31, 2021 | 145.40M | -79.94% |
| Dec 31, 2020 | 724.80M | -55.52% |
| Dec 31, 2019 | 1.63B | 32.13% |
| Dec 31, 2018 | 1.23B | -28.50% |
| Dec 29, 2017 | 1.72B | 510.80% |
| Dec 30, 2016 | 282.40M | -43.67% |
| Dec 31, 2015 | 501.30M | -39.08% |
| Dec 31, 2014 | 822.90M | 290.00% |
| Dec 31, 2013 | 211.00M | 3.38% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Korro Bio | 422.57M |
| C4 Therapeutics | 414.90M |
| Editas Medicine | 411.19M |
| Anika Therapeutics | 409.47M |
| Sonida Senior Living | 407.46M |
| Cerus | 406.76M |
| Alto Neuroscience | 402.99M |
| Precigen | 401.35M |